GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line

Read Time:7 Second

The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

This week’s aggressive Fed rate cut could provide some breathing space for distressed companies, notes one bankruptcy attorney.

Investors are mulling strategies beyond cash on expectations that interest rates will continue to fall after the Fed’s big rate...

The package-delivery giant said reduced demand for priority services and higher operating costs weighed on results.

Elliott Hill will replace John Donahoe as chief executive next month, following months of struggles for the athletic-wear giant.

It’s that time again: Investors will see option contracts tied to more than $5 trillion in tradeable stocks expire on...

Mortgage rates inched up even though the Federal Reserve cut interest rates. Experts explain why this is a short-lived phenomenon.